ATE513921T1 - Verfahren zur herstellung reifer insulinpolypeptide - Google Patents

Verfahren zur herstellung reifer insulinpolypeptide

Info

Publication number
ATE513921T1
ATE513921T1 AT06778234T AT06778234T ATE513921T1 AT E513921 T1 ATE513921 T1 AT E513921T1 AT 06778234 T AT06778234 T AT 06778234T AT 06778234 T AT06778234 T AT 06778234T AT E513921 T1 ATE513921 T1 AT E513921T1
Authority
AT
Austria
Prior art keywords
human insulin
insulin polypeptides
mature insulin
producing mature
chain
Prior art date
Application number
AT06778234T
Other languages
English (en)
Inventor
Asser Sloth Andersen
Lars Hojlund Christensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE513921T1 publication Critical patent/ATE513921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT06778234T 2005-08-16 2006-08-15 Verfahren zur herstellung reifer insulinpolypeptide ATE513921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107513 2005-08-16
PCT/EP2006/065303 WO2007020256A1 (en) 2005-08-16 2006-08-15 Method for making mature insulin polypeptides

Publications (1)

Publication Number Publication Date
ATE513921T1 true ATE513921T1 (de) 2011-07-15

Family

ID=35169284

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778234T ATE513921T1 (de) 2005-08-16 2006-08-15 Verfahren zur herstellung reifer insulinpolypeptide

Country Status (7)

Country Link
US (1) US9056921B2 (de)
EP (1) EP1917363B1 (de)
JP (2) JP5366546B2 (de)
CN (2) CN102660614A (de)
AT (1) ATE513921T1 (de)
ES (1) ES2368500T3 (de)
WO (1) WO2007020256A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE513921T1 (de) 2005-08-16 2011-07-15 Novo Nordisk As Verfahren zur herstellung reifer insulinpolypeptide
WO2008037735A1 (en) * 2006-09-27 2008-04-03 Novo Nordisk A/S Method for making maturated insulin polypeptides
WO2008062010A2 (en) * 2006-11-22 2008-05-29 Novo Nordisk A/S Method for making activated carboxypeptidases
US20130295605A1 (en) * 2010-05-28 2013-11-07 Csir Method for producing a polypeptide in yarrowia lipolytica
MY186251A (en) * 2014-01-20 2021-06-30 Hanmi Pharm Ind Co Ltd Long-acting insulin and use thereof
AU2015328222B9 (en) * 2014-10-06 2020-12-24 Case Western Reserve University Biphasic single-chain insulin analogues
PL233560B1 (pl) 2014-12-05 2019-10-31 Mabion Spolka Akcyjna Sposób otrzymywania insuliny lub analogu insuliny z prekursora rekombinowanego białka
UY36870A (es) 2015-08-28 2017-03-31 Hanmi Pharm Ind Co Ltd Análogos de insulina novedosos
AU2017332408B2 (en) 2016-09-23 2022-02-10 Hanmi Pharm. Co., Ltd. Insulin analogs with reduced affinity to insulin receptor and use thereof
AU2017361524B2 (en) * 2016-11-21 2022-06-02 Case Western Reserve University Rapid-acting insulin analogues of enhanced stability
WO2018174668A2 (ko) 2017-03-23 2018-09-27 한미약품 주식회사 인슐린 수용체와의 결합력이 감소된 인슐린 아날로그의 결합체 및 이의 용도
TW202039437A (zh) 2018-12-11 2020-11-01 法商賽諾菲公司 肽黏合劑

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4914026A (en) 1983-04-07 1990-04-03 Chiron Corporation Alpha factor leader sequence directed secretion of insulin
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
AU600885B2 (en) 1984-05-25 1990-08-30 Zymogenetics Inc. Stable DNA constructs
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
JP2523562B2 (ja) 1985-10-25 1996-08-14 ザイモジェネティックス インコーポレーテッド 外来タンパク質を分泌することを目的としたｂａｒ１の使用法
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
WO1990001038A1 (en) 1988-07-20 1990-02-08 Nordisk Gentofte A/S Human insulin analogs and preparations containing them
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
HUT56857A (en) 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
IL93282A (en) 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues
FI914898A0 (fi) 1989-04-20 1991-10-17 Sinai School Medicine Leverspecifika insulinanaloger.
DK300090D0 (da) 1990-12-19 1990-12-19 Novo Nordisk As Fremgangsmaade til fremstilling af leadersekvenser
US6348327B1 (en) 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
DK82893D0 (da) 1993-07-08 1993-07-08 Novo Nordisk As Peptid
NZ273285A (en) 1993-09-17 1997-10-24 Novo Nordisk As Insulin derivatives and compositions thereof
US6011007A (en) 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
US5639642A (en) 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
ZA954983B (en) 1994-06-17 1996-02-14 Novo Nordisk As N-terminally extended proteins expressed in yeast
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
US5646242A (en) 1994-11-17 1997-07-08 Eli Lilly And Company Selective acylation of epsilon-amino groups
GB9513967D0 (en) * 1995-07-08 1995-09-06 Univ Leicester Insulin
US20030104981A1 (en) * 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
US6451970B1 (en) 1996-02-21 2002-09-17 Novo Nordisk A/S Peptide derivatives
EP0909312B1 (de) 1996-07-05 2002-12-04 Novo Nordisk A/S Verfahren zur produktion von polypeptiden
WO1998032867A1 (en) 1997-01-24 1998-07-30 Novo Nordisk A/S Synthetic leader peptide sequences
JP4795599B2 (ja) * 1999-12-29 2011-10-19 ノボ ノルディスク アクティーゼルスカブ 酵母において改良された発酵収率を有するインスリン前駆体及びインスリン前駆体類似体の製造方法
EP1377608B1 (de) * 2001-04-02 2009-09-16 Novo Nordisk A/S Insulinvorstufen und verfahren zu deren herstellung
ATE513921T1 (de) 2005-08-16 2011-07-15 Novo Nordisk As Verfahren zur herstellung reifer insulinpolypeptide
WO2008037735A1 (en) 2006-09-27 2008-04-03 Novo Nordisk A/S Method for making maturated insulin polypeptides
WO2008062010A2 (en) 2006-11-22 2008-05-29 Novo Nordisk A/S Method for making activated carboxypeptidases

Also Published As

Publication number Publication date
EP1917363A1 (de) 2008-05-07
JP2013208119A (ja) 2013-10-10
CN102660614A (zh) 2012-09-12
CN101243190B (zh) 2015-05-13
JP5366546B2 (ja) 2013-12-11
EP1917363B1 (de) 2011-06-22
CN101243190A (zh) 2008-08-13
WO2007020256A1 (en) 2007-02-22
US9056921B2 (en) 2015-06-16
ES2368500T3 (es) 2011-11-17
JP2009504169A (ja) 2009-02-05
US20110111460A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
MX2009002388A (es) Uso de celulas humanas originarias de leucemia mieloide para la expresion de anticuerpos.
MXPA05013723A (es) Metodos para loa produccion de insulina en plantas.
BRPI0811177A2 (pt) Titulações de polipeptídeo do fator viii em culturas de células
PH12013500995A1 (en) Methods for increasing yield and fine chemical production in plants
WO2008005847A3 (en) Method of producing factor viii proteins by recombinant methods
MY150249A (en) Systems and methods for carbon capture and sequestration and compositions derived therefrom
UA103176C2 (ru) Растение с повышенными показателями урожайности и способ его получения
MY185872A (en) Cell culture improvements
MY149949A (en) Apparatus comprising a circular buffer and method for assigning redundancy versions to a circular buffer
MX2014005779A (es) Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
NZ598417A (en) Modifying glycoprotein production in plants
NZ600540A (en) Ethanol production in non-recombinant hosts
DE602004008183D1 (de) Verfahren zur Herstellung von L-Cystein unter Verwendung eines zur Gattung Escherichia gehörenden Bakteriums
WO2005087802A3 (en) Process for producing polypeptides
WO2006128764A3 (en) Process for cultivating animal cells comprising the feeding of plant-derived peptones
TN2009000516A1 (en) Protein production in plants
BR112012017243A2 (pt) constructos terapêuticos de apirase, agentes de apirase, e métodos de produção
WO2004111074A3 (en) In vivo production of a clostridial neurotoxin light chain peptide
Mariano et al. Strain localization due to crack–microcrack interactions: X-FEM for a multifield approach
ATE486944T1 (de) Translationselongationsfaktor-promotor aus pichia pastoris und verfahren zur herstellung von rekombinantem protein unter verwendung davon
PH12012501810A1 (en) Plants having enhanced yield-related traits and method for making the same
DK2207795T3 (da) Fremgangsmåde til fremstilling af modent rekombinant gruppe I-mideallergen
DE602005017034D1 (de) Signalpeptid zur herstellung eines polypeptids
ES2530760T3 (es) Peptidasas de basidiomicetos
EP2067857A4 (de) Verfahren zur dipeptidherstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties